Guard Therapeutics International AB (GUARD) — Cash Flow-to-Debt Ratio
Guard Therapeutics International AB (GUARD) has a Cash Flow-to-Debt Ratio of -5.95x as of September 2025, meaning its operating cash flow of Skr-90.70 Million could theoretically repay -6% of its total liabilities (Skr15.24 Million) in one year. See Guard Therapeutics International AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guard Therapeutics International AB Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Guard Therapeutics International AB across 13 annual periods. Also explore GUARD net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guard Therapeutics International AB (2012–2024)
Year-by-year debt coverage analysis for Guard Therapeutics International AB. For market capitalisation and broader financial context, see Guard Therapeutics International AB market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.33x | Skr-94.75 Million | Skr17.77 Million | ▲ +15.0% |
| 2023 | -6.27x | Skr-116.05 Million | Skr18.49 Million | ▼ -55.1% |
| 2022 | -4.05x | Skr-102.14 Million | Skr25.24 Million | ▲ +23.6% |
| 2021 | -5.29x | Skr-77.59 Million | Skr14.66 Million | ▼ -60.8% |
| 2020 | -3.29x | Skr-37.96 Million | Skr11.54 Million | ▲ +39.4% |
| 2019 | -5.43x | Skr-60.21 Million | Skr11.09 Million | ▼ -180.6% |
| 2018 | -1.93x | Skr-58.46 Million | Skr30.21 Million | ▲ +65.8% |
| 2017 | -5.65x | Skr-66.01 Million | Skr11.68 Million | ▼ -45.9% |
| 2016 | -3.87x | Skr-46.98 Million | Skr12.13 Million | ▼ -17.9% |
| 2015 | -3.28x | Skr-29.56 Million | Skr9.00 Million | ▼ -173.2% |
| 2014 | -1.20x | Skr-6.87 Million | Skr5.71 Million | ▼ -825.1% |
| 2013 | -0.13x | Skr-2.83 Million | Skr21.75 Million | ▼ -54.7% |
| 2012 | -0.08x | Skr-1.45 Million | Skr17.25 Million | — |